Economic evaluation of programmes aiming at eradicating infectious diseases

Health Policy

Volumn 45, Issue 1, 1998, Pages 69-79

  Gyldmark, Marlene ^a   Alban, Anita ^b  

^a NOVO NORDISK A S   (Denmark)

^b Danish Inst Hlth Serv R and D   (Denmark)

Author keywords

Economic evaluation; Eradicable diseases; Health policy; Infectious diseases

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INFECTION PREVENTION; MALARIA; MEASLES; POLICY; POLIOMYELITIS;

COMMUNICABLE DISEASE CONTROL; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DECISION MAKING, ORGANIZATIONAL; FEMALE; HEALTH CARE RATIONING; HEALTH POLICY; HEALTH SERVICES RESEARCH; HUMANS; MALE; NATIONAL HEALTH PROGRAMS; POLICY MAKING; PROGRAM EVALUATION; REGIONAL MEDICAL PROGRAMS;

EID: 0031903171     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8510(98)00032-3     Document Type: Article

References (10)

1. Bart KJ, Foulds J, Patricarca P. Global Eradication of Poliomyelitis: Benefit Cost Analysis. Bulletin of World Health Organization 1997:35-45.
2. Gold MR, Siegel J, Russell LB, Weinstein MC, editors. Cost-effectiveness in Health and Medicine. Oxford: Oxford University Press, 1996.
3. Archarya A, Murray CJL. Economic appraisal of eradication programs: The problem of infinite benefits. In: Dowdle WR, Hopkins DR, editors. The Eradication of Infectious Diseases. London: Wiley, 1998.
4. Mishan EJ. Cost Benefit Analysis. London: Allen and Unwin, 1988.
5. Taylor Commission. The Impact of the Expanded Programme on Immunisation and the Polio Eradication Initiative on Health Systems in the Americas. Washington: Pan American Health Organisation, 1995.
6. Canadian Coordinating Office for Health Technology Assessment, CCOHTA. Guidelines for Economic Evaluation of Pharmaceuticals, 1st ed. Ottawa: CCOHTA, 1994.
7. Commonwealth Department of Human Services and Health. Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee. Canberra: Australian Government Publishing Service, 1996.
8. Jamison DT, Mosley WH, Measham AR, Bobadilla JL, editors. Disease Control Priorities in Developing Countries. Oxford: Oxford University Press, 1993.
9. Morbidity and Mortality Weekly Report, MMWR. Recommendations of the International Task Force for Disease Eradication. CDC publication 93-8017. U.S. Dept. of Health and Human Services, 1993.
10. Murray CJL, Lopez AD, editors. The Global Burden of Disease. A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Boston, MA: Harvard School of Public Health, WHO, World Bank, 1996.